Detalles de la búsqueda
1.
A practical guide for assessing and managing cardiovascular risk during androgen-deprivation therapy in patients with prostate cancer.
Cancer
; 130(11): 1916-1929, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38529566
2.
Hepatic prohibitin 1 and methionine adenosyltransferase α1 defend against primary and secondary liver cancer metastasis.
J Hepatol
; 80(3): 443-453, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38086446
3.
Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation.
Cancer Immunol Immunother
; 73(6): 110, 2024 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38662248
4.
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions.
J Urol
; 211(4): 526-532, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38421252
5.
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy.
J Urol
; 211(4): 509-517, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38421253
6.
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy.
J Urol
; 211(4): 518-525, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38421243
7.
HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma.
Hepatology
; 77(3): 774-788, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35908246
8.
Antagonizing CD105 and androgen receptor to target stromal-epithelial interactions for clinical benefit.
Mol Ther
; 31(1): 78-89, 2023 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36045587
9.
A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models.
BMC Cancer
; 23(1): 499, 2023 Jun 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37268911
10.
Cancer epithelia-derived mitochondrial DNA is a targetable initiator of a paracrine signaling loop that confers taxane resistance.
Proc Natl Acad Sci U S A
; 117(15): 8515-8523, 2020 04 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32238563
11.
Variation in Communication of Competing Risks of Mortality in Prostate Cancer Treatment Consultations.
J Urol
; 208(2): 301-308, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35377775
12.
Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma.
Hepatology
; 73(1): 422-436, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32017145
13.
Disparities in Cancer Care and the Asian American Population.
Oncologist
; 26(6): 453-460, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33683795
14.
Integrating PARP Inhibitors Into Advanced Prostate Cancer Therapeutics.
Oncology (Williston Park)
; 35(3): 119-125, 2021 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33818052
15.
An Open Label Phase Ib Dose Escalation Study of TRC105 (Anti-Endoglin Antibody) with Axitinib in Patients with Metastatic Renal Cell Carcinoma.
Oncologist
; 24(2): 202-210, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30190302
16.
Circulating tumor cells in prostate cancer: beyond enumeration.
Clin Adv Hematol Oncol
; 15(1): 63-73, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28212371
17.
Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium Study.
Prostate
; 76(3): 286-93, 2016 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26493492
18.
Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database.
Cancer
; 122(2): 222-9, 2016 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26484853
19.
Plasma Glutamine as a Prognostic Biomarker in Localized Prostate Cancer: Comparison of Conventional Variables in Risk Stratification.
Oncology (Williston Park)
; 35(9): 528-535, 2021 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34524771
20.
Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases.
Cancer
; 121(18): 3240-51, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25975562